Jyoti Srivastava, PhD, discusses a study investigating methods to boost inhibitor function in advanced melanoma.
Jyoti Srivastava, PhD
Advertisement
Jyoti Srivastava, PhD, is a senior research scientist at Moffitt Cancer Center.
Articles by Jyoti Srivastava, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5
